Customers / Cellerant Therapeutics
Coupa Helps Biotech Startup Grow Purchasing, Not Head Count
As a young Biotech company, Cellerant prides itself on in-house innovation. But its internally developed procurement system was hampering efficiency and visibility for procurement. They needed quick cure and got one with Coupa.
Cellerant is a biotech company developing human stem cell and antibody therapies for oncology and blood-related disorders.
San Carlos, CA
- Previous web-based procurement software was difficult to scale, upgrade, and maintain.
- Biggest limiting factor was lack of visibility in the approval process.
- Turnkey SaaS model was more efficent than internally developed platform.
- Visibility and metrics allow greater insight.
- UI Ease-of-use drove effortless adoption.